Header Logo

Connection

Erica Browne to Humans

Back to Details
This is a "connection" page, showing publications Erica Browne has written about Humans.
Erica Browne
Connection Strength
1.603
Humans
  1. Acceptability of the dapivirine vaginal ring for HIV-1 prevention among women reporting engagement in transactional sex. AIDS Care. 2024 01; 36(1):80-86.
    View in: PubMed
    Score: 0.096
  2. Incorporating end-users' voices into the development of an implant for HIV prevention: a discrete choice experiment in South Africa and Zimbabwe. BMC Womens Health. 2023 02 10; 23(1):58.
    View in: PubMed
    Score: 0.095
  3. Patterns of Adherence to a Dapivirine Vaginal Ring for HIV-1 Prevention Among South African Women in a Phase III Randomized Controlled Trial. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):418-424.
    View in: PubMed
    Score: 0.091
  4. Efficacy is Not Everything: Eliciting Women's Preferences for a Vaginal HIV Prevention Product Using a Discrete-Choice Experiment. AIDS Behav. 2020 May; 24(5):1443-1451.
    View in: PubMed
    Score: 0.078
  5. A Bayesian Analysis of a Randomized Clinical Trial Comparing Antimetabolite Therapies for Non-Infectious Uveitis. Ophthalmic Epidemiol. 2017 02; 24(1):63-70.
    View in: PubMed
    Score: 0.062
  6. Higher Acceptability of the Monthly Dapivirine Ring Versus Daily Oral Pre-Exposure Prophylaxis Among Adolescent Girls and Young Women in Sub-Saharan Africa in the REACH Trial. J Acquir Immune Defic Syndr. 2025 Dec 15; 100(5):415-424.
    View in: PubMed
    Score: 0.029
  7. Measuring Pre-Exposure Prophylaxis (PrEP) Stigma Among Adolescent Girls and Young Women in Western Kenya: Scale Development, Validation, and Associations with PrEP Adherence. AIDS Patient Care STDS. 2025 Aug; 39(8):323-338.
    View in: PubMed
    Score: 0.028
  8. Short-Term Effects of Peer-Bullying Victimization on Intimate Partner Violence. Am J Prev Med. 2025 Sep; 69(3):107943.
    View in: PubMed
    Score: 0.028
  9. Longer-acting preexposure prophylaxis product and delivery preferences among U.S. populations disproportionately affected by HIV: a discrete choice experiment. AIDS. 2025 Aug 01; 39(10):1364-1374.
    View in: PubMed
    Score: 0.028
  10. PrEP knowledge, attitudes, and perceived barriers to access among American Indian/Alaska Native people in the US: Results from an online survey. PLoS One. 2025; 20(4):e0321422.
    View in: PubMed
    Score: 0.028
  11. Greater Improvements in Vaccination Outcomes Among Black Young Adults With Vaccine-Resistant Attitudes in the United States South Following a Digital Health Intervention: Latent Profile Analysis of a Randomized Control Trial. JMIR Public Health Surveill. 2025 Apr 16; 11:e67370.
    View in: PubMed
    Score: 0.028
  12. Evaluation of the Tu'Washindi Na PrEP Intervention to Reduce Gender-Based Violence and Increase Preexposure Prophylaxis Uptake and Adherence Among Kenyan Adolescent Girls and Young Women: Protocol for a Cluster Randomized Controlled Trial. JMIR Res Protoc. 2025 Apr 01; 14:e55931.
    View in: PubMed
    Score: 0.027
  13. Effectiveness of an empowerment-based self-defense program among South African girls: results from a cluster-randomized control trial in schools. BMC Womens Health. 2025 Mar 14; 25(1):119.
    View in: PubMed
    Score: 0.027
  14. Ecological momentary assessment study of same-hour polysubstance use among people who use opioids and additional substances. Drug Alcohol Depend. 2025 Apr 01; 269:112582.
    View in: PubMed
    Score: 0.027
  15. Criminal legal system engagement among people who use drugs in Oregon following decriminalization of drug possession. Drug Alcohol Depend. 2024 Nov 01; 264:112449.
    View in: PubMed
    Score: 0.026
  16. We choose: Adolescent girls and young women's choice for an HIV prevention product in a cross-over randomized clinical trial conducted in South Africa, Uganda, and Zimbabwe. PLoS One. 2024; 19(8):e0308577.
    View in: PubMed
    Score: 0.026
  17. Correlates of Adherence to Oral and Vaginal Pre-exposure Prophylaxis (PrEP) Among Adolescent Girls and Young Women (AGYW) Participating in the MTN-034/REACH Trial. AIDS Behav. 2024 Sep; 28(9):2990-3000.
    View in: PubMed
    Score: 0.026
  18. Organize and mobilize for implementation effectiveness to improve overdose education and naloxone distribution from syringe services programs: a randomized controlled trial. Implement Sci. 2024 Feb 28; 19(1):22.
    View in: PubMed
    Score: 0.025
  19. Health risks associated with smoking versus injecting fentanyl among people who use drugs in California. Drug Alcohol Depend. 2024 Feb 01; 255:111053.
    View in: PubMed
    Score: 0.025
  20. Breaking down relationship barriers to increase PrEP uptake and adherence among adolescent girls and young women in Kenya: safety and preliminary effectiveness results from a pilot cluster-randomized trial. J Int AIDS Soc. 2023 12; 26(12):e26198.
    View in: PubMed
    Score: 0.025
  21. Impact of a high-volume overdose prevention site on social and drug disorder in surrounding areas in San Francisco. Drug Alcohol Depend. 2023 11 01; 252:110969.
    View in: PubMed
    Score: 0.025
  22. Evaluating oxygen monitoring and administration during overdose responses at a sanctioned overdose prevention site in San Francisco, California: A mixed-methods study. Int J Drug Policy. 2023 Nov; 121:104165.
    View in: PubMed
    Score: 0.025
  23. The Effects of Participation in an Intensive HIV Prevention Trial on Long-Term Socio-Demographic Outcomes Among Young Women in Rural South Africa. J Acquir Immune Defic Syndr. 2023 05 01; 93(1):1-6.
    View in: PubMed
    Score: 0.024
  24. "My Family Was Also Happy": Couples' Qualitative Reports of a Combined Behavioral Economics and Cognitive Behavioral Therapy Intervention to Reduce Alcohol Use and Intimate Partner Violence. Violence Against Women. 2024 Sep; 30(11):2901-2916.
    View in: PubMed
    Score: 0.024
  25. Nonurgent Emergency Department Use Among Women Sentenced to Probation. J Correct Health Care. 2023 Jun; 29(3):182-189.
    View in: PubMed
    Score: 0.024
  26. Couples' Preferences for "2 in 1" Multipurpose Prevention Technologies to Prevent Both HIV and Pregnancy: Results of a Discrete Choice Experiment in Uganda and Zimbabwe. AIDS Behav. 2022 Dec; 26(12):3848-3861.
    View in: PubMed
    Score: 0.023
  27. Using narratives to inform the development of a digital health intervention related to COVID-19 vaccination in Black young adults in Georgia, North Carolina and Alabama. Vaccine. 2022 11 15; 40(48):6908-6916.
    View in: PubMed
    Score: 0.023
  28. Social environment risk factors for violence, family context, and trajectories of social-emotional functioning among Latinx adolescents. J Adolesc. 2022 12; 94(8):1118-1129.
    View in: PubMed
    Score: 0.023
  29. The CHARISMA Randomized Controlled Trial: A Relationship-Focused Counseling Intervention Integrated Within Oral PrEP Delivery for HIV Prevention Among Women in Johannesburg, South Africa. J Acquir Immune Defic Syndr. 2022 08 01; 90(4):425-433.
    View in: PubMed
    Score: 0.023
  30. Couples' decision making regarding the use of multipurpose prevention technology (MPT) for pregnancy and HIV prevention. AIDS Behav. 2023 Jan; 27(1):198-207.
    View in: PubMed
    Score: 0.023
  31. Early Sexual Debut and Neighborhood Social Environment in Latinx Youth. Pediatrics. 2022 03 01; 149(3).
    View in: PubMed
    Score: 0.022
  32. Acceptability of an extended duration vaginal ring for HIV prevention and interest in a multi-purpose ring. PLoS One. 2022; 17(2):e0263664.
    View in: PubMed
    Score: 0.022
  33. Effect of an Unsanctioned Safe Consumption Site in the United States on Syringe Sharing, Rushed Injections, and Isolated Injection Drug Use: A Longitudinal Cohort Analysis. J Acquir Immune Defic Syndr. 2022 02 01; 89(2):172-177.
    View in: PubMed
    Score: 0.022
  34. Reduced Emergency Department Visits and Hospitalisation with Use of an Unsanctioned Safe Consumption Site for Injection Drug Use in the United States. J Gen Intern Med. 2022 11; 37(15):3853-3860.
    View in: PubMed
    Score: 0.022
  35. The Role of Families in Adolescent and Young Adults' PrEP Use. AIDS Behav. 2022 May; 26(5):1618-1632.
    View in: PubMed
    Score: 0.022
  36. Improved syringe disposal practices associated with unsanctioned safe consumption site use: A cohort study of people who inject drugs in the United States. Drug Alcohol Depend. 2021 12 01; 229(Pt A):109075.
    View in: PubMed
    Score: 0.022
  37. Transition from injecting opioids to smoking fentanyl in San Francisco, California. Drug Alcohol Depend. 2021 10 01; 227:109003.
    View in: PubMed
    Score: 0.021
  38. Long-Acting Injection and Implant Preferences and Trade-Offs for HIV Prevention Among South African Male Youth. J Acquir Immune Defic Syndr. 2021 07 01; 87(3):928-936.
    View in: PubMed
    Score: 0.021
  39. Acceptability of the Dapivirine Vaginal Ring for HIV-1 Prevention and Association with Adherence in a Phase III Trial. AIDS Behav. 2021 Aug; 25(8):2430-2440.
    View in: PubMed
    Score: 0.021
  40. Family and School Connectedness Associated with Lower Depression among Latinx Early Adolescents in an Agricultural County. Am J Community Psychol. 2021 09; 68(1-2):114-127.
    View in: PubMed
    Score: 0.021
  41. Impact of an unsanctioned safe consumption site on criminal activity, 2010-2019. Drug Alcohol Depend. 2021 03 01; 220:108521.
    View in: PubMed
    Score: 0.020
  42. Preferences for long-acting Pre-Exposure Prophylaxis (PrEP) for HIV prevention among South African youth: results of a discrete choice experiment. J Int AIDS Soc. 2020 06; 23(6):e25528.
    View in: PubMed
    Score: 0.020
  43. Hygiene, Blood Flow, and Vaginal Overload: Why Women Removed an HIV Prevention Vaginal Ring During Menstruation in Malawi, South Africa, Uganda and Zimbabwe. AIDS Behav. 2020 Feb; 24(2):617-628.
    View in: PubMed
    Score: 0.019
  44. A Combined Behavioral Economics and Cognitive Behavioral Therapy Intervention to Reduce Alcohol Use and Intimate Partner Violence Among Couples in Bengaluru, India: Results of a Pilot Study. J Interpers Violence. 2021 12; 36(23-24):NP12456-NP12480.
    View in: PubMed
    Score: 0.019
  45. Insights for Implementation Science From 2 Multiphased Studies With End-Users of Potential Multipurpose Prevention Technology and HIV Prevention Products. J Acquir Immune Defic Syndr. 2019 12; 82 Suppl 3:S222-S229.
    View in: PubMed
    Score: 0.019
  46. First Impressions Matter: How Initial Worries Influence Adherence to the Dapivirine Vaginal Ring. J Acquir Immune Defic Syndr. 2019 07 01; 81(3):304-310.
    View in: PubMed
    Score: 0.018
  47. Time Trade-off Utility Values in Noninfectious?Uveitis. Am J Ophthalmol. 2019 12; 208:47-55.
    View in: PubMed
    Score: 0.018
  48. End-user preference for and choice of four vaginally delivered HIV prevention methods among young women in South Africa and Zimbabwe: the Quatro Clinical Crossover Study. J Int AIDS Soc. 2019 05; 22(5):e25283.
    View in: PubMed
    Score: 0.018
  49. Young Women's Stated Preferences for Biomedical HIV Prevention: Results of a Discrete Choice Experiment in Kenya and South Africa. J Acquir Immune Defic Syndr. 2019 04 01; 80(4):394-403.
    View in: PubMed
    Score: 0.018
  50. Polydrug use patterns, risk behavior and unmet healthcare need in a community-based sample of women who use cocaine, heroin or methamphetamine. Addict Behav. 2018 10; 85:94-99.
    View in: PubMed
    Score: 0.017
  51. Difluprednate for the Treatment of Uveitic Cystoid Macular Edema. Am J Ophthalmol. 2018 07; 191:14-22.
    View in: PubMed
    Score: 0.017
  52. Demographic and Operational Factors Predicting Study Completion in a Multisite Case-Control Study of Preschool Children. Am J Epidemiol. 2018 03 01; 187(3):592-603.
    View in: PubMed
    Score: 0.017
  53. The Tablets, Ring, Injections as Options (TRIO) study: what young African women chose and used for future HIV and pregnancy prevention. J Int AIDS Soc. 2018 03; 21(3):e25094.
    View in: PubMed
    Score: 0.017
  54. Distinguishing Features of Ocular Sarcoidosis in an International Cohort of Uveitis Patients. Ophthalmology. 2018 01; 125(1):119-126.
    View in: PubMed
    Score: 0.016
  55. Quality-of-Life Outcomes From a Randomized Clinical Trial Comparing Antimetabolites for Intermediate, Posterior, and Panuveitis. Am J Ophthalmol. 2017 Jul; 179:10-17.
    View in: PubMed
    Score: 0.016
  56. Assessment of the Accuracy of Using ICD-9 Codes to Identify Uveitis, Herpes Zoster Ophthalmicus, Scleritis, and Episcleritis. JAMA Ophthalmol. 2016 Sep 01; 134(9):1001-6.
    View in: PubMed
    Score: 0.015
  57. Outcomes of Vogt-Koyanagi-Harada Disease: A Subanalysis From a Randomized Clinical Trial of Antimetabolite Therapies. Am J Ophthalmol. 2016 Aug; 168:279-286.
    View in: PubMed
    Score: 0.015
  58. Association between Smoking and Uveitis: Results from the Pacific Ocular Inflammation Study. Ophthalmology. 2015 Jun; 122(6):1257-61.
    View in: PubMed
    Score: 0.014
  59. A randomized clinical trial comparing methotrexate and mycophenolate mofetil for noninfectious uveitis. Ophthalmology. 2014 Oct; 121(10):1863-70.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.